Found: 6
Select item for more details and to access through your institution.
PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02070-x
- By:
- Publication type:
- Article
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01196-x
- By:
- Publication type:
- Article
A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035423
- By:
- Publication type:
- Article
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging.
- Published in:
- Scientific Reports, 2016, p. 39284, doi. 10.1038/srep39284
- By:
- Publication type:
- Article
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 725, p. 1, doi. 10.1126/scitranslmed.adi2556
- By:
- Publication type:
- Article
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations.
- Published in:
- 2017
- By:
- Publication type:
- journal article